Generics

Camber’s enalapril maleate oral solution is indicated for the treatment of hypertension to lower blood pressure in adults and children age one month old and older.

The program, designed to refer patients for dispensing of Ascend brand medications, is slated to launch in the first quarter of 2022.

The medication, which is the generic of Compazine, is used to control severe nausea and vomiting, as well as treat schizophrenia.

Amneal is introducing dexamethasone, azacitidine, carboprost and atropine for the institutional market.

The medication is indicated in the treatment of infections caused by susceptible strains of designated organisms in certain diseases when oral administration is not possible.

Lamotrigine ODT is indicated for epilepsy adjunctive therapy in patients aged 2 years old and older, epilepsy monotherapy in patients aged 16 years old and older, and maintenance of bipolar I disorder.

Digoxin tablets have a market value of roughly $2.1 million for the 12 months ending December 2021, according to IQVIA.

Roflumilast tablets are indicated as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.